We invite you to engage in an interactive roundtable with leading neurologists, researchers, and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.
Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in our research, which will be expanded to include analyzing data from wearables and smartphones.
As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below.
This is an invite only event.
June 13th 2022 - 3:30PM EST, 12:30PM PST
Indu Navar, EverythingALS
Welcome and opening remarks
Keynote: Kate Nycz
Elad Yom-Tov, Microsoft Research
Validating the ability to Detect ALS through Search Engine Interactions: BING
Amir Lahav, Mitsubishi Tanabe Pharma Holdings America
Patients Perspective on Digital Biomarkers
Alan Taitz, EverythingALS
New Discoveries in EverythingALS Studies
Meera Gandhi, EverythingALS
New Study Kickoff - Multi-Modal, Remote and Supervised
Sensors and Wearables
Moderator: Wendy Ehler, Astra Zeneca
Open discussion and questions
Closing remarks and next steps